prediction of pulmonary arterial pressure in chronic obstructive pulmonary disease by radionuclide...
TRANSCRIPT
DOI 10.1378/chest.96.6.1280 1989;96;1280-1284Chest
P Mols, C H Huynh, P Dechamps, N Naeije, M Guillaume and H Ham radionuclide ventriculography.chronic obstructive pulmonary disease by Prediction of pulmonary arterial pressure in
http://chestjournal.chestpubs.org/content/96/6/1280
can be found online on the World Wide Web at: The online version of this article, along with updated information and services
) ISSN:0012-3692http://chestjournal.chestpubs.org/site/misc/reprints.xhtml(without the prior written permission of the copyright holder.reserved. No part of this article or PDF may be reproduced or distributedChest Physicians, 3300 Dundee Road, Northbrook, IL 60062. All rights
ofbeen published monthly since 1935. Copyright1989by the American College is the official journal of the American College of Chest Physicians. It hasChest
© 1989 American College of Chest Physicians by guest on July 11, 2011chestjournal.chestpubs.orgDownloaded from
1280 Prediction of Pulmonary Arterial Pressure in COPD (Mo!s St a!)
Prediction of Pulmonary Arterial Pressurein Chronic Obstructive Pulmonary Diseaseby Radionuclide Ventriculography*Pierre Mols, M.D.; Chi-Hoang Huynh, M.D.; Philippe Dechanips, M.D.;
Nicole NaeUe, M. D. ; Marcel Guillaunte, Ph. D. ; and
Hamphrey Hani, M.D. , Ph.D.
Pulmonary arterial hypertension represents an important
parameter for the assessment of the severity of chronic
bronchitis. The measurement of the pulmonary arterial
pressure, however, requires invasive techniques of limitedroutine use because of costs and associated risks. The aim
of this study is to evaluate whether the 81”Kr right ventric-
ular ejection fraction and parameters derived from equilib-
rium �‘Tc red blood cells’ right ventricular curve allow a
better estimation ofPAP than the �Tc RVEF. In 41 patients
with severe chronic bronchitis, the linear correlation be-
tween PAP and �Tc RVEF was - 0.61 (p<O.OOl). None of
the parameters derived from the right ventricular curve
was better correlated to PAP than the �Tc RVEF. In 16
other chronic bronchitis patients, the 8I�(j. RVEF correlated
moderately to PAl?. In conclusion, the alternative isotopic
methods proposed in this work do not provide a reliable
estimation of pulmonary arterial pressure in patients with
chronic bronchitis. (Chest 1989; 96:1280-84
PAP = pulmonary artery pressure; RVEF right ventricularejection fraction; ROl region of interest
C hronic o)bstructive pulmonary disease is one of the
chief causes of disability and death in Europe
and in the United States. Pulmonary hypertension
triggers the development of right ventricular hyper-
trophy which may lead to right ventricular failure with
a high mortality rate.’3 The measurement of PAP
requires right heart catheterization. Although this
technique is widely available, its routine use is limited
by co)sts and associated risks. Therefore, less invasive
methods have been developed to detect and assess
the severity of pulmonary hypertension. One of these
methods is the determination ofRVEF by technetium-
99m radionuclide ventriculography. Studies, however,
show that the ventricular ejection fraction lacks in
specificity and poorly correlates with pulmonary ar-
terial pressure.4’5
During the last few years, however, radionuclide
techniques have improved considerably and some
curve parameters have shown a better sensitivity than
*From the Service of Internal Medicine and of Radio-Isotopes,
Saint-Pierre University I lospital , Brussels, Belgium.Manuscript received April 7; revision accepted May 18.Reprint requests: Dr. Mols, Garde Adults, Hopital Universitaire-St-Pierre, B-1000 Brussels, Belgium
RVEF in assessing pulmonary arterial pressure.6’7 An
improved method for the evaluation of the RVEF by
krypton-8lm (81’�Kr) has also been developed.�’�
The aim ofthis study was to evaluate whether ��mKr
RVEF and parameters derived from equilibrium tech-
netium-99m red blood cells (mmTc RBC) right ventric-
tilar curve allow a better estimation of pulmonary
arterial pressure.
Patients
MATERIAL AND METHODS
Fifty seven patients with stable and severe chronic obstructive
pulmonary disease were subjected to right heart catheterization to
measure pulmonary arterial pressure and estimate right ventricular
function. There were 53 men and four women (group 1: 64 ± 3
years; group 2: 61 ± 1 years). No patient had any clinical or
electrocardiographic evidence of systemic hypertension, valvular
heart disease or coronary artery disease. The patients’ characteris-
tics and lung function data are given in Table 1 . All the patients
have given informed consent to) the study, which was approved by
the Human Investigation Committee of our institution.
Hemodynamic Determination
A triple lumen thermodilution 7F Swan-Ganz catheter was
introdticed into the right internal jugular vein using the Seldinger
technique, and advanced under constant pressure wave and fluor-
Table 1 -Patients’ Characteristics and Lung Function Data
N* Age, yr
Male!
Female
FEV
mI-s �
FEV1/FEV1,
%
PaO�,
mm Hg
PaCO2,
mm Hg
Groupi 16 64±3 16-0 953±122 40±3 64±4 44±2
Group 2 41 61 ± 1 37!4 912 ± 63 39 ± 6 64 ± 2 43 ± 1
*N, number O)fpatients; values are expressed as mean ± SEM.
© 1989 American College of Chest Physicians by guest on July 11, 2011chestjournal.chestpubs.orgDownloaded from
TINE
U-LU>
E
0?
a
a
60
50
40
30
a a
aa a
y - 54.8317 . O.6127x R = 0.76
a
aa
CHEST I 96 I 6 I DECEMBER, 1989 1281
C)0Cz-I
z
-�
m
FIGURE 1 . Parameters calculated from the right ventricular curve
during the systolic and diastolic phases. For the signification of the
abbreviations, see methods.
oscopic control in the right pulmonary artery. Pulmonary pressure
was measured using a physiologic pressure transducer and recorded
on a thermal writing recorder. The zero reference was placed at
midchest level and values for pressures were averaged for three
successive respiratory cycles. Heart rate was derived from a
continuously monitored ECG lead. Cardiac output was measured
in triplicate by the thermodilution method using a computer. The
following formulae were used for hemodynamic calculations: cardiac
index (l/min/m2) = cardiac output (L/min) ! body surface area (rn2);
pulmonary vascular resistance index (dyne.s.cm -��m2) 80 X (mean
pulmonary arterial pressure - pulmonary wedge pressure)!cardiac
index.
Right Ventricular Ejection Fraction Techniques
In 16 patients (group 1), RVEF was determined using TM1”Krwithin
the seven days following right heart catheterization. The detailed
procedure of the 5”Kr right ventricular study has been described
previously.� Briefly, the patient was studied supine, in a 30� right
anterior oblique projection. The ‘�“Kr was continuously infused and
16 ECG-gated frames were acquired. Background activity was
corrected using �‘Tc MAA lung perfusion scintigraphy acquired in
the same position immediately after the completion of the gated
study. End-diastolic and end-systolic right ventricular ROIs were
carefully delineated on the background corrected images taking
into account isocount lines and the phase and amplitude images of
the first and second Fourier harmonics constnicted from the original
70
gated data. In 41 patients (group 2), ECG-gated equilil)rlum �“Tc
RBC ventriculography was performed simultaneously with right
heart catheterization. The patient was studied supine in 45#{176}left
anterior oblique projection and 16 ECG-gated frames were ac-
quired. End-diastolic right ventricular ROI was delineated following
the limits o)f the ventricular phase area. For background correction,
50 percent o)f the maximum activity in the right ventricular area in
the end-diastolic frame was subtracted o�n each pixel of the 16
gated-frames. The end-systolic right ventricular ROI was therefore
automatically defined. The RVEF was calculated using the classical
end-diastolic mintis end-systolic over end-diastolic count rates. A
three-harmonics Fourier curve fitting was then applied on the
corrected right ventricular volume curve;1#{176}#{176}and the following
parameters were calculated (Fig 1): pre-ejection period, ms; time
to the first third of the systole, ms; time to peak ejection rate, ms;
total ejection time, ms; first third ejection rate, countss ‘; peak
ejection rate, co)unts-s ‘; mean ejection rate, counts-s ‘; first third
ejection on total ejection, VFEITE; rapid filing time, ms; slow filing
time, Ins; time to the first third diastole, ms; time to peak filing
rate, ms; total filing time, ms; first third filing rate, counts-s ‘; peakfiling rate, counts-s � mean filing rate, co)unts-s ‘; and first third
filing on total filing, FTFIFF.
Study Protocol
In group 1 , ‘1”Kr RVEF was measured at rest and correlated to)
the pulmonary hemodynamic measurements performed during the
same week.
In group 2, ‘#{176}“TcRVEF and the other noninvasive parameters
were correlated to) pulmonary arterial pressures and resistances
measured simultaneousl�:
Statistics
These co)nsisted oflinear, logarithmic and exponential correlations
between no)ninvasive parameters and pulmonary hemodynarnics.
RESULTS
The plotting of sih1lKr RVEF and mean pulmonary
arterial pressure, presented in Figure 2, shows that
both parameters are correlated (r - 0.75) though not
perfectly.
Correlations between curve parameters derived
from the ECG-gated right volume curve and mean
pulmonary arterial pressure are presented in Table 2.
None ofthese curve parameters correlates better with
mean pulmonary arterial pressure than RVEF even
when using a logarithmic or exponential correlation
10 20 30
Mean pulmonary arterial pressure, mmHg.
, FIGuRE 2. Linear correlation between 81”Kr right yen-
4 0 tricular ejection fraction and mean pulmonary arterial
pressure in 16 patients with COPD.
© 1989 American College of Chest Physicians by guest on July 11, 2011chestjournal.chestpubs.orgDownloaded from
Cs
U
fC
. ,�
:s�!:�/�!
: :� R-049 �
�: �#{176} H:
:,‘H .� �.
�B #{149}�
U g #{149}� #{149}�
y - 1.873 ‘0.0278x R - 0.34
40 50 ‘o ‘ i’s ‘ 20 ‘ 30 ‘ 40 50
pressure, mmHg. Mean pulmonary arterial pressure, mmHg.
third ejection rate
patients with COPD.
and FIGURE 4. Linear correlation between first third filling rate and
mean pulmonary arterial pressure in 41 patients with COPD.
Table 2-Linear Correlation Between Radionuclide and HeInOd*JnamiC Parameters.
1282 Prediction of Pulmonary Arterial Pressure in COPD (Mo!s St a!)
PAP PAPS PVRI
Systolic phase
Pre-ejection period ms + 0. 10 + 0.05 + 0.14
Time to peak ejection rate ms + 0.24� + 0.26* + 0.30t
lime to first third systole ms +0.24k +0.23� +0.28t
Totalejectiontime ms +0.04 +0.09 +0.14
First third ejection rate count-s ‘ - 0.49� - 0.52� - 0.38�
Peak ejection rate count-s’ - 0.29t - 0.351 - 0.28�
Mean ejection rate co - 0.43� - 0.461 - 0.414
First third/total ejection rate count-s ‘ + 0. 17 + 0. 10 + 0.13
TPER-PEP� ms +0.14 +0.19 +0.15
Diastolic phase
Rapidfillingtime ms -0.06 -0.04 -0.07
Slow filling time ms �0.23�
Time to peak filling rate ms +0.01 +0.01 -0.01
‘Lime to first third diastole ms + 0.02 + 0.06 + 0.05
Total filling time ms -0.2&#{176} -0.24k �0.22�
Peak filling rate count-s’ - 0. 13 - 0.19 - 0.15
First third filling rate count-s’ -0.34� -0.35t
Mean filling rate count-s’ -0.23� -0.27t -0.22�
First third to total filling rate -0.15 -0.19 �0.22�
RV ejection fraction % - 0.61t -0.631 -0.54�
�0 = p<O.O5.
tp<0.01.
:tp<0.001.
§TPER-PEP, time to peak ejection-rate pre-ejection period.
instead of a linear correlation. Figures 3 and 4 show
the calculated parameters of the systolic and diastolic
phases which correlate best with mean pulmonary
arterial pressure, respectively first third ejection and
filing rate.
The same results have been observed with the
systolic pulmonary arterial pressure and the pulmo-
nary vascular resistance index (Table 2).
DISCUSSION
In chronic obstructive pulmonary disease, pulmo-
nary arterial hypertension frequently induces cor
pulmonale and symptomatic right congestive heart
failure with poor �3 The higher the pulmo-
nary arterial pressure, the worse the prognosis. There-
fore, the determination ofthis parameter seems inter-
esting for both the evaluation and the follow-up of
COPD patients. Since measuring pulmonary arterial
pressure requires right heart catheterization, a trau-
matic and expensive procedure, a variety of other
techniques have been proposed, including chest roent-
genography, echocardiography, radionuclide angiog-
raphy and others.’2’7 Unfortunately, up to now, none
ofthem has yielded accurate estimations of pulmonary
arterial pressure.
The most commonly used radionuclide parameter
is the RVEF. Indeed, correlations have been found
between pulmonary arterial pressure and RVEF, but
within both the normal and abnormal range, the
variability of estimated pulmonary arterial pressure is
important and small changes in RVEF may reflect
large variations in pulmonary pressure . Therefore,
more reliable radionuclide parameters have been
sought. Friedman and Holman6 used regional RVEF
© 1989 American College of Chest Physicians by guest on July 11, 2011chestjournal.chestpubs.orgDownloaded from
CHEST I 96 I 6 I DECEMBER, 1989 1283
during the second half of systole and noted that this
improved accuracy in evaluating pulmonary arterial
hypertension as compared to the global ejection
fraction. However, in their report, accurate and repro-
ducible results were said to require a high degree of
proficiency. Marmor et al� proposed another index
composed by RVEF and right atrial emptying rate. In
their hands, this parameter seems to evaluate the
severity of pulmonary arterial hypertension very pre-
cisely.
We were interested in other radionuclide ap-
proaches. First, we used sImKr radionuclide ventricu-
lography because it solves most of the technical
problems posed by classical methods: the surimposi-
tion ofthe heart chambers for equilibrium techniques,
the low count rate or low resolution for first pass study,
for instance. But the correlation between 8�’Kr RVEF
and pulmonary arterial pressure hardly improved and
the range of pulmonary arterial values corresponding
to each RVEF was still too large. The use of 81”Kr
RVEF as an accurate pulmonary arterial pressure
predictor index was thus questioned.
Second, the use of right ventricular curve parame-
ters derived from a Y9mTc red blood cells ECG gated
equilibrium study. Indeed, systolic or diastolic delays,
right ventricular ejection or filling speed have not yet
been tested as indices evaluating pulmonary arterial
pressure. But neither systolic nor diastolic delays
could be correlated with pulmonary arterial pressure
in our work.
In contrast, Marchandise et al’� found a correlation
between the acceleration time measured by Doppler
echocardiography and PAP in patients with COPD.
In our study, the time between the onset and peak
pulmonary flow velocity is reflected by the difference
between time to peak ejection rate and pre-ejection
period. This parameter has not allowed an accurate
evaluation of pulmonary arterial pressure. The dis-
crepancies between our results and Marchandise’s
suggest that the measurement of systolic and diastolic
delays might be less accurate by the isotopic method
than by the Doppler technique. This is probably due
to the surimposition of the right auricle and the right
ventricle. Moreover, the evaluation of mean pulmo-
nary arterial pressure by parameters derived from a
right ventricular equilibrium curve rather than the
evaluation of pulmonary arterial pressure values dur-
ing one heart cycle implies less precise measurements
because of chest movements and a variability in
duration of the heart cycles.
The speed ofright ventricular emptying at different
moments of the systolic phase decreases when pul-
monary hypertension increases in our work. Since the
right ventricular contractility either does not change
or increases with deteriorating pulmonary fu’8
the decrease ofright ventricular emptying speed might
be caused by an increase of RV afterload, and thus, o)f
pulmonary arterial pressure. Unfortunately, in our
work, those indices correlate to) 20 to 25 percent of
measured pulmonary arterial pressure and are of no
clinical interest fur evaluating pulmonary arterial
pressure.
Finally, our findings sugj�est a slightly negative
correlation between pulmonary arterial pressure and
right ventricular filling speed during the first third of
diastole. This slower early filling speed of the right
ventricle is probably to be ascribed to a decreased
compliance secondary to both muscular hypertrophy
and chamber dilation observed in COPD with pt’1-
monary yp’9
In conclusion, our findings show that pulmonary
hypertension in patients with COPD affects both the
systolic and diastolic phase of the right ventricular
function. The isotopic methods proposed do not yet
provide a reliable estimation of pulmonary arterial
pressure in our patients.
REFERENCES
1 Bishop JM, Cross KW. Physiological variables and mortality in
patients with various categories of chronic respiratory disease.
Bull Eur Physiopath Respir 1984; 20:495-500
2 Weitzenblum E, Loiseau A, Hirth C, Mirhom R, Rasaholinja-
nahary J. Course of pulmonary hemodynamics in patients with
chronic obstructive pulmonary disease. Chest 1979; 75:656-62
3 Fishman AP Chronic cor pulmonale. Am Rev Respir Dis 1976;
114:775-94
4 Brent BN, Mahler D, Matthay BA, Berger HJ, Zaret BL.
Noninvasive diagnosis of pulmonary arterial hypertension in
chronic obstructive pulmonary disease: right ventricular ejection
fraction at rest. Am J Cardiol 1984; 53:1349-53
5 Morrison DA, Goldman 5, Wright AL, Henry R, Sorenson S,
Caldwell J, et al. The effect of pulmonary hypertension on
systolic function ofthe right ventricle. Chest 1983; 84:250-57
6 Friedman BJ, Holman BL. Scintigraphic prediction of pulmo-
nary arterial systolic pressure by regional right ventricular
ejection fraction during the second halfofsystole. Am J Cardiol
1982; 50:1114-19
7 MarmorAT, MijiritskyY, Plich M, FrenkelA, Front D. Improved
radionuclide method for assessment of pulmonary artery pres-
sure in COPD. Chest 1986; 89:64-69
8 Morisson DA, Turgeon J, Ovitt T. Right ventricular ejection
fraction measurement: contrast ventriculography versus gated
blood pool and gated first-pass radionuclide methods. Am JCardiol 1984; 54:651-53
9 Ham HR, Franken PR, Georges B, Delcourt E, Guillaume M,
Piepsz A. Evaluation ofthe accuracy ofthe steady-state krypton
81-m method for calculating right ventricular ejection fraction.
J NucI Med 1986; 27:593-60110 Bacharach SL, Green M\� Vitale D, White G, Bonow RO,
Douglas MA, et al. Fourier filtering cardiac time activity curves:
sharp cutoff filters. In: Deconinck F. Information processing in
medical imaging. Martinus Nijhoff Publisher, 1984:266-81
11 Bacharach SL, Green MV, Vitale D, Withe G, Douglas MA,
Bonow RO, et al. Optimum Fourier filtering of cardiac data: a
minimum error method. J Nucl Med 1983; 24:1176-84
12 Matthay BA, Schwarz MI, Hellis JH, Steele PP. Siebert PE,
Durance JR. et al. Pulmonary artery hypertension in chronic
obstructive pulmonary disease: determination by chest radiog-
raphy. Invest Radiol 1981; 16:95-100
© 1989 American College of Chest Physicians by guest on July 11, 2011chestjournal.chestpubs.orgDownloaded from
American Board of Internal Medicine,Subspecialty Examination in Pulmonary Disease
The 1990 subspecialty examination in pulmonary disease has been announced by the ABIM.
The registration period is January 1-April 1, 1990 and the examination date is November 6,1990. For information, contact the Registration Section, ABIM, 3624 Market Street, Philadel-phia 19104 (800:441-ABIM).
1284 Prediction of Pulmonary Arterial Pressuie in COPD (Mo!s St a!)
13 Zenker G, Forche G, Harnoncourt K. Two-dimensional echo-
cardiography using a subeostal approach in patients with COPD.
Chest 1985; 88:722-25
14 Marchandise B, De Bruyne B, Delaunois L, Kremer R. Nonin-
vasive prediction ofpulmonary hypertension in chronic obstruc-
tive pulmonary disease by doppler echocardiography. Chest
1987; 91:361-65
15 Brent B, Berger HJ, Matthay BA, Mahler D, Pytlik L, Zaret B.
Physiologic correlates of right ventricular ejection fraction in
chronic obstructive pulmonary disease: a combined radionuclide
and hemodynamic study. Am J Cardiol 1982; 50:255-62
16 Korr KS, Gandsman EJ, Winkler ML, Shulman RS, Bough EW
Hemodynamic correlates of right ventricular ejection fraction
measured with gated radionuclide angiography. Am J Cardiol
1982; 49:71-77
17 Bernard R, Smets P, Nicaise J, Vanhoute C, Kremer R, Denolin
H. Correlation entre l’electrocardiogramme et la pression
art#{233}rielle pulmonaire dans les pneumopathies chroniques. Bull
WHO 1973; 49:155-65
18 Stein PD, Sabbah HN, Anbe DT, Marzilli M. Performance of
the failing and nonfailing right ventricle of patients with pul-
monary hypertension. Am J Cardiol 1979; 44:1050-55
19 Rahlf G. Chronic cor pulmonale. Virchows Arch Pathol Anat
Histol 1978; 378:273-86
© 1989 American College of Chest Physicians by guest on July 11, 2011chestjournal.chestpubs.orgDownloaded from
DOI 10.1378/chest.96.6.1280 1989;96; 1280-1284Chest
P Mols, C H Huynh, P Dechamps, N Naeije, M Guillaume and H Hamdisease by radionuclide ventriculography.
Prediction of pulmonary arterial pressure in chronic obstructive pulmonary
July 11, 2011This information is current as of
http://chestjournal.chestpubs.org/content/96/6/1280Updated Information and services can be found at:
Updated Information & Services
http://chestjournal.chestpubs.org/content/96/6/1280#related-urlsThis article has been cited by 1 HighWire-hosted articles:
Cited Bys
http://www.chestpubs.org/site/misc/reprints.xhtmlonline at: Information about reproducing this article in parts (figures, tables) or in its entirety can be foundPermissions & Licensing
http://www.chestpubs.org/site/misc/reprints.xhtmlInformation about ordering reprints can be found online:
Reprints
the right of the online article.Receive free e-mail alerts when new articles cite this article. To sign up, select the "Services" link to
Citation Alerts
slide format. See any online figure for directions. articles can be downloaded for teaching purposes in PowerPointCHESTFigures that appear in Images in PowerPoint format
© 1989 American College of Chest Physicians by guest on July 11, 2011chestjournal.chestpubs.orgDownloaded from